These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1137127)

  • 61. [Lactic acidosis associated with various types of biguanide-therapy (phenformin, buformin, metformin). Results of a survey of the years 1972--1977 in Switzerland (author's transl)].
    Berger W; Amrein R
    Schweiz Rundsch Med Prax; 1978 May; 67(18):661-7. PubMed ID: 652724
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
    Kiho T; Kato M; Usui S; Hirano K
    Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of potential risks of lactic acidosis induction by biguanides in rats.
    Bando K; Ochiai S; Kunimatsu T; Deguchi J; Kimura J; Funabashi H; Seki T
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):155-60. PubMed ID: 20488215
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of ion-pair methods to drug extraction from biological fluids. I. Quantitative determination of biguanides in urine.
    Garrett ER; Tsau J
    J Pharm Sci; 1972 Sep; 61(9):1404-10. PubMed ID: 5068946
    [No Abstract]   [Full Text] [Related]  

  • 65. [Biguanide-induced and - associated lactic acidosis: serum and tissue biguanide levels in hyperlactaemia and lactic acidosis (author's transl)].
    Irsigler K; Kritz H; Regal H; Kaspar L
    Wien Klin Wochenschr; 1979 Jan; 91(2):59-65. PubMed ID: 433281
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Oral treatment of diabetes mellitus. Clinical experience of Metformin or Phenformin alone and combined treatment with these biguanides and P-607].
    AKAZAWA Y
    Naika Hokan; 1962; 9():337-46. PubMed ID: 14011506
    [No Abstract]   [Full Text] [Related]  

  • 67. Rapid determination of metformin in human plasma by liquid chromatography-tandem mass spectrometry method.
    Chen X; Gu Q; Qiu F; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):377-81. PubMed ID: 15018802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
    Sogame Y; Kitamura A; Yabuki M; Komuro S
    Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gas chromatographic determination of beta-phenethylbiguanide and its metabolite p-hydroxy-beta-phenethylbiguanide in serum and urine.
    Mottale M; Stewart CJ
    J Chromatogr; 1975 Mar; 106(2):263-70. PubMed ID: 1150796
    [TBL] [Abstract][Full Text] [Related]  

  • 71. NBR2-GLUT1 axis regulates cancer cell sensitivity to biguanides.
    Zhang X; Lin HK
    Cell Cycle; 2017 Feb; 16(3):249-250. PubMed ID: 27929708
    [No Abstract]   [Full Text] [Related]  

  • 72. Carbohydrate biguanides as potential hypoglycemic agents.
    Reitz AB; Tuman RW; Marchione CS; Jordan AD; Bowden CR; Maryanoff BE
    J Med Chem; 1989 Sep; 32(9):2110-6. PubMed ID: 2769683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats.
    Schlienger JL; Frick A; Marbach J; Freund H; Imler M
    Diabete Metab; 1979 Mar; 5(1):5-9. PubMed ID: 446834
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical pharmacology of oral hypoglycemic drugs].
    Tatoń J
    Pol Tyg Lek; 1968 Sep; 23(34):1289-92. PubMed ID: 5722532
    [No Abstract]   [Full Text] [Related]  

  • 75. [Vitamin B12-level in serum of diabetics receiving long-term buformin therapy].
    Müller P; Fischer H; Sorger D
    Z Gesamte Inn Med; 1981 Mar; 36(6):226-8. PubMed ID: 7257460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
    Vigneri R; Pezzino V; Wong KY; Goldfine ID
    J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metformin: historical overview.
    Bailey CJ
    Diabetologia; 2017 Sep; 60(9):1566-1576. PubMed ID: 28776081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Biguanides and lactate acidosis; consequences for registration advice].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1979 Feb; 123(8):298-301. PubMed ID: 418931
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacokinetic optimisation of oral hypoglycaemic therapy.
    Marchetti P; Giannarelli R; di Carlo A; Navalesi R
    Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes.
    Ubl JJ; Chen S; Stucki JW
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):561-7. PubMed ID: 7998993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.